Redmile Group, Llc Insider Profile
11 Followers
Redmile Group, Llc, Director at Atara Biotherapeutics, holds 2.17M shares in Attovia Therapeutics, Inc. (Ticker: ATTO), holds 636.85K shares in Atara Biotherapeutics (Ticker: ATRA), holds 12.88M shares in Fate Therapeutics (Ticker: FATE). Most recently, Redmile Group, Llc Bought ― shares of Attovia Therapeutics, Inc. on Aug 07, 2026 for an estimated value of $10.20M.
Redmile Group, Llc Atara Biotherapeutics (ATRA)Director
Atara Biotherapeutics (ATRA)
Director
Ranked #6,213 out of 108,328 Corporate Insiders
Profitable Transactions
21 out of 45 Profitable Transactions
Average Return
+12.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
A breakdown of Redmile Group, Llc's holdings
Insider Roles
Roles that Redmile Group, Llc holds in companies
Most Profitable Insider Trade
The most profitable trade made by Redmile Group, Llc
Redmile Group, Llc's Trading History
Atara Biotherapeutics
Jul 24, 2026
Director
Uninformative Buy
1.59M
$5.34M
Attovia Therapeutics, Inc.
Aug 07, 2026
Ten Percent Owner
Informative Buy
10.20M
―
Array Biopharma
Sep 30, 2016
―
Informative Sell
15.85M
$916.36M
Amicus
Jun 13, 2016
―
Informative Buy
477.36K
$186.78M
Alder Biopharmaceuticals
Oct 24, 2019
―
Uninformative Sell
―
$0.00
Xeris Pharmaceuticals
Feb 21, 2019
Ten Percent Owner
Informative Buy
5.88M
$24.25M
Allakos
Jul 24, 2018
―
Uninformative Buy
―
$331.99K
Replimune Group
Jul 25, 2018
Ten Percent Owner
Uninformative Buy
―
$8.73M
Fate Therapeutics
Apr 22, 2026
Director, Ten Percent Owner
Uninformative Sell
―
$31.57M
Gritstone bio
Oct 03, 2018
―
Uninformative Buy
―
$15.34K
Vapotherm
Nov 16, 2018
―
Uninformative Buy
―
$2.08M
TCR2 Therapeutics
Feb 21, 2019
―
Uninformative Buy
―
$1.19M
Hookipa Pharma
Apr 24, 2019
―
Uninformative Buy
―
$1.15M
IGM Biosciences
Aug 15, 2025
―
Uninformative Sell
―
$0.00
Cabaletta Bio
Oct 29, 2019
Ten Percent Owner
Uninformative Buy
―
$1.87M
Aprea Therapeutics
Feb 16, 2021
Ten Percent Owner
Informative Sell
2.79M
$1.10M
Atreca
Jun 24, 2019
―
Uninformative Buy
―
$64.38K
Akero Therapeutics
Jun 24, 2019
―
Uninformative Buy
―
$40.65M
Stoke Therapeutics
Jun 24, 2019
Ten Percent Owner
Uninformative Buy
―
$19.39M
Beam Therapeutics
Feb 11, 2020
Ten Percent Owner
Uninformative Buy
―
$29.64M
Neurogene
Apr 06, 2020
Ten Percent Owner
Informative Sell
220.10K
$132.92M
Pliant Therapeutics
Jun 09, 2020
Ten Percent Owner
Uninformative Buy
―
$1.99M
Repare Therapeutics
Jun 25, 2020
―
Uninformative Buy
―
$4.20M
Nurix Therapeutics
Jul 30, 2020
Ten Percent Owner
Uninformative Buy
―
$27.31M
Annexon Biosciences
Jul 30, 2020
Ten Percent Owner
Uninformative Buy
―
$8.13M
Kalaris Therapeutics
Aug 05, 2020
Ten Percent Owner
Uninformative Buy
―
$2.89M
Kymera Therapeutics
Aug 25, 2020
Ten Percent Owner
Uninformative Buy
―
$168.61M
Shattuck Labs
Dec 06, 2024
Director, Ten Percent Owner
Informative Sell
166.71K
$39.17M
Verve Therapeutics
Jun 23, 2021
―
Informative Buy
19.95M
$21.55M
AbSci
Jun 14, 2024
Director
Uninformative Buy
―
$64.28M
Invivyd
Aug 12, 2021
Ten Percent Owner
Uninformative Buy
―
$1.81M
Science 37
Mar 13, 2024
―
Uninformative Sell
5.85M
$0.00
Augmedix
Oct 04, 2024
―
Uninformative Sell
75.40M
$0.00
Entrada Therapeutics Inc
Nov 04, 2021
Ten Percent Owner
Informative Buy
20.00M
$13.27M
MedAvail Holdings
Jul 06, 2022
Director, Ten Percent Owner
Uninformative Buy
18.07M
$2.69M
Zymeworks
Oct 17, 2022
Ten Percent Owner
Uninformative Buy
153.32K
$133.31M
RayzeBio, Inc.
Sep 21, 2023
―
Uninformative Buy
―
$116.09M
ADC Therapeutics
Apr 02, 2026
Ten Percent Owner
Informative Sell
19.59M
$24.08M
List of latest transactions for each holding click on a transaction to see Redmile Group, Llc's performance on stock
You May Also Like
Redmile Group, Llc insider profile FAQ
What is the percentage of profitable transactions made by Redmile Group, Llc?
The percentage of profitable transactions made by Redmile Group, Llc is 47%.
What is the average return per transaction made by Redmile Group, Llc?
The average return per transaction made by Redmile Group, Llc is 12.10%.
What stocks does Redmile Group, Llc hold?
Redmile Group, Llc holds: ATRA, ATTO, ~ARRY, FOLD, ALDR, XERS, ALLK, REPL, FATE, GRTSQ, VAPO, TCRR, HOOK, IGMS, CABA, APRE, BCEL, AKRO, STOK, BEAM, NGNE, PLRX, RPTX, NRIX, ANNX, KLRS, KYMR, STTK, VERV, ABSI, IVVD, SNCE, AUGX, TRDA, MDVLQ, ZYME, RYZB, ADCT stocks.
What was Redmile Group, Llc’s latest transaction?
Redmile Group, Llc latest transaction was an Informative Buy of $10.20M.
What was Redmile Group, Llc's most profitable transaction?
Redmile Group, Llc’s most profitable transaction was an Informative Buy of FATE stock on June 17, 2020. The return on the trade was 165.20%.
What is Redmile Group, Llc's role in Atara Biotherapeutics?
Redmile Group, Llc's role in Atara Biotherapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.